Atrium Health Teammates Make Their Mark at ASCO’s 2023 Annual Meeting

This June, teammates from Atrium Health Levine Cancer Institute (LCI), Atrium Health Wake Forest Baptist Comprehensive Cancer Center, and the Wake Forest University School of Medicine attended the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Atrium Health leaders and researchers led or co-authored more than 30 posters, oral abstracts, and presentations to advance cancer care and scientific knowledge. A sample of LCI's numerous poster presentations on recent research findings included:

• Dr. Earle Burgess, chief of LCI’s Genitourinary Oncology program, shared ENZADA trial results — a phase II study initiated at LCI.

• Dr. Daniel Carrizosa, a co-author on a national phase II randomized study, shared research findings related to extensive stage small cell lung cancer.

• Dr. Nilanjan Ghosh, chief of LCI’s Lymphoma Division and chair of the Department of Hematologic Oncology and Blood Disorders, presented on outcomes by race in patients with chronic lymphocytic leukemia.

During the annual meeting, several LCI teammates received prestigious accolades. Dr. Antoinette R. Tan, chair of Solid Tumor Oncology and Investigational Therapeutics at LCI, was named a Fellow of the American Society of Clinical Oncology (FASCO) in recognition of her extraordinary volunteer service and engagement with ASCO. Dr. Ashley Sumrall, section chief of Neuro-Oncology at LCI, was recognized as ASCO’s “Advocate of the Year” for 2022. Dr. Declan Walsh, LCI's Hemby Family Endowed Chair in Supportive Oncology, received one of ASCO’s highest honors — the Walther Cancer Foundation Endowed Supportive Oncology Award — for his leadership and contributions to supportive oncology and palliative care.